Form Filed By Zeskind Benjamin J.
Wed, Jun 18, 2025
Go to original document
Immuneering Corp (IMRX)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2025-06-18
Class A Common Stock
Purchase
P
Type
Acquired 21,000 shares @ $2.39 per share
2,302,852 shares
Direct
Class A Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
894,927 shares
See Foonote
Indirect
Footnotes
1. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.31 to $2.44. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
2. Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.